Comprehensive Comparison of listed companies in China's third-party medical diagnosis industry in 2024 (with business layout summary, performance comparison, etc.)

Core data of this paper: summary of listed third-party medical diagnosis enterprises; The proportion of listed enterprises in the third-party medical diagnosis industry; Third party medical diagnosis listed enterprise development planning

Summary of listed companies in the third-party medical diagnosis industry

From the perspective of the industrial chain, the upstream industry of the third-party medical diagnosis industry is the manufacturing industry of medical devices, diagnostic reagents, consumables, etc., and the downstream is the institution that provides medical services for patients.

The listed companies in the third-party diagnostic industry mainly include: Golden Field Medical (603882.SH), Capu Biological (300639.SZ), Shengxiang Biological (688289.SH), Meikang Biological (300439.SZ), etc.

Note: The statistical scope of Yunkang Group and Adicom Holdings in 2024 is the first half of the year.

Comparison of business layout of listed companies in the third-party medical diagnosis industry

In the development of China's third-party medical diagnosis industry, Kingland Medical and Shengxiang Biological, as the main enterprises in the field of third-party medical diagnosis, have greater advantages in terms of business scale and business scope. Leading enterprises such as Adicom and Kingfield Medical have a high concentration of third-party medical diagnosis business layout, while enterprises such as Ade Biology have integrated the in vitro diagnostic reagents, instruments and third-party medical diagnosis service industry chain. From the perspective of the overall layout of listed enterprises in the industry, most enterprises focus on domestic.

Note: The statistical scope of Shengxiang's biological business proportion data is 2023, and the rest of the enterprises are in the first half of 2024, the same below.

Comparison of business performance of listed companies in the third-party medical diagnosis industry

From the perspective of revenue scale, domestic Dean Diagnostics and Golden Field Medical are two leading enterprises in third-party medical diagnostics. The gross profit margin of the tripartite medical diagnosis business fluctuates greatly, and the layout content of the third-party medical diagnosis company is slightly different. The enterprises with high gross profit margin include Berry Gene, Ade Biological, BGI and so on.

Note: The statistical scope of data of Capp Biological and Shengxiang Biological is 2023, and that of other enterprises is the first half of 2024.

Business planning of listed companies in the third-party medical diagnosis industry

In the context of the continuous development and growth of downstream medical and other industries, China has promulgated a number of policies in recent years to promote the development of third-party medical diagnosis industry. The business planning of China's main listed third-party medical diagnosis enterprises is as follows: